Verona Pharma plc Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Verona Pharma plc quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Verona Pharma plc Return On Equity for the quarter ending June 30, 2024 was -55.4 %, a 173% decline year-over-year.
  • Verona Pharma plc annual Return On Equity for 2023 was -20.5 %, a 47.5% increase from 2022.
  • Verona Pharma plc annual Return On Equity for 2022 was -39 %, a 12.7% decline from 2021.
  • Verona Pharma plc annual Return On Equity for 2021 was -34.6 %, a 42.5% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -55.4 -35.1 -173% Apr 1, 2024 Jun 30, 2024
Q1 2024 -25.1 +3.24 +11.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -20.5 +18.5 +47.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -19.4 +32.9 +62.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -20.3 +19.3 +48.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -28.3 +11.3 +28.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -39 -4.4 -12.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -52.4 -18.8 -55.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -39.6 +9.57 +19.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -39.6 +11.9 +23% Jan 1, 2022 Mar 31, 2022
Q4 2021 -34.6 +25.5 +42.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -33.6 Jul 1, 2021 Sep 30, 2021
Q2 2021 -49.2 Apr 1, 2021 Jun 30, 2021
Q1 2021 -51.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 -60.1 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.